drug development
Search documents
X @Forbes
Forbes· 2025-11-22 23:03
Funding & Investment - Profluent has secured $106 million in funding to advance its AI models for biological applications [1] - Jeff Bezos is supporting Profluent, an AI startup focused on programmable proteins [1] Technology & Application - Profluent is scaling up the use of its AI models in drug development and agriculture [1] - The company's focus is on making proteins programmable using AI [1]